SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 16, 2026

IONS

IONIS PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $3.6M total
Actionable Insight • Neutral

No material signal from this cluster. Monitor for larger insider sales (>0.5% of market cap) or a cluster of open-market purchases by C-suite executives, which would carry stronger informational content.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IONS ▼ -27.05% at T+60d
NEUTRAL call -27.05% · α vs SPY -30.20% · entry $74.31 → $54.21
Entry = T+0 close
Jun 16, 2026
via day close
T+1d
-0.26%
call -0.26% · α -1.04%
$74.12
settled 4mo ago
T+5d
+2.97%
call +2.97% · α +4.02%
$76.52
settled 4mo ago
T+20d
-26.46%
call -26.46% · α -27.77%
$54.65
settled 3mo ago
T+60d
-27.05%
call -27.05% · α -30.20%
$54.21
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two IONIS insiders (a Director and the EVP/Chief Development Officer) sold a combined $3.59M in open-market shares after exercising stock options. The total sales represent only ~0.03% of the company's $12.2B market cap, making this a routine, liquidity-driven cluster with no material informational signal.

Key Financial Metrics

Direction
selling
Total Value
$3.6M
Insiders
2

Key Facts

  • Director Spencer R. Berthelsen sold 8,000 shares at $73.49 for $587,920 on June 15, 2026, following a derivative exercise.
  • EVP/Chief Development Officer Holly B. Kordasiewicz sold 41,004 shares at $73.09 for $3.00M on June 12, 2026, following derivative exercises.
  • Total insider sales of $3.59M represent ~0.03% of IONS' $12.2B market cap.
  • Both sales were preceded by option exercises, consistent with routine tax- or liquidity-driven transactions.

Financial Impact

Insider sales of $3.59M are trivial relative to $12.2B market cap (0.03%).

dilutioninsider ownership

Risk Factors

  • Insider sales could accelerate if the stock continues to appreciate, but current levels are routine.
  • Option exercises may increase share count modestly, but the impact is negligible.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (33 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IONS-1781645227794
24 reports for IONS
Performance horizon
57% Hit rate @ T+20 4 of 7 directional calls Went positive at some point 7 of 9 best @ T+60▲ +32.25%Jul 9, 2026
Filters
Rows
Reports for IONS — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
8-K
BULLISH ★ 7/10
$42.93awaiting T+20—$43.42 (+1.14%)
Oct 21, 2026
5d ago
8-K
BULLISH ★ 7/10
$43.91awaiting T+20—$43.42 (−1.12%)
Oct 21, 2026
5d ago
Institutional Cluster
MIXED ★ 3/10
$43.91awaiting T+20—$43.42 (−1.12%)
Sep 23, 2026
4w ago
8-K
BULLISH ★ 7/10
$43.93 $44.27▲ +0.77%▲ +0.09%$43.42 (−1.16%)
Sep 4, 2026
7w ago
8-K
BEARISH ★ 7/10
$56.71 $44.00▲ +22.41%▲ +24.13%$43.42 (+23.44%)
Sep 4, 2026
7w ago
8-K
BULLISH ★ 7/10
$58.09 $43.50▼ −25.12%▼ −25.72%$43.42 (−25.25%)
Jul 31, 2026
12w ago
Insider Buy
NEUTRAL ★ 4/10
$54.49 $60.36▲ +10.77%▲ +9.53%$43.42 (−20.32%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$54.04 $63.36▲ +17.25%▲ +12.23%$43.42 (−19.65%)
Jul 9, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$58.25 $56.56▼ −2.90%▼ −5.33%$43.42 (−25.46%)
Jul 9, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$58.25 $56.56▼ −2.90%▼ −5.33%$43.42 (−25.46%)
Showing 10 of 24

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 16, 2026